Genetics: predisposition and management.
作者信息
Legare Robert D
机构信息
Department of Obstetrics, Gynecology and Medicine, Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA.
出版信息
Clin Obstet Gynecol. 2011 Mar;54(1):180-90. doi: 10.1097/GRF.0b013e31820940d1.
PMID:21278518
Abstract
摘要
相似文献
1
Genetics: predisposition and management.
Clin Obstet Gynecol. 2011 Mar;54(1):180-90. doi: 10.1097/GRF.0b013e31820940d1.
2
Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
Nat Clin Pract Oncol. 2006 Apr;3(4):182-3. doi: 10.1038/ncponc0456.
3
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Clin Cancer Res. 2008 May 1;14(9):2861-9. doi: 10.1158/1078-0432.CCR-07-4436.
4
Improving surveillance and quality of life of BRCA mutation carriers.
J Clin Oncol. 2010 Aug 1;28(22):e376-7. doi: 10.1200/JCO.2010.28.7334. Epub 2010 May 10.
5
[BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
Lakartidningen. 2004 Jun 17;101(25):2172-7.
6
[Clinical and molecular diagnosis of inherited breast-ovarian cancer].
J Gynecol Obstet Biol Reprod (Paris). 2003 Apr;32(2):101-19.
7
BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Breast Cancer Res. 2006;8(1):R3. doi: 10.1186/bcr1365. Epub 2005 Dec 12.
8
Hereditary breast and ovarian cancer syndrome.
Gynecol Oncol. 2009 Apr;113(1):6-11. doi: 10.1016/j.ygyno.2009.02.017.
9
Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Eur J Cancer Prev. 2000 Jun;9(3):139-50.
10
BRCA1 and BRCA2 cancer risks.
J Clin Oncol. 2006 Jul 10;24(20):3312-3; author reply 3313-4. doi: 10.1200/JCO.2006.06.7934.
Zotero 插件